Immuneering
IMRX
IMRX
35 hedge funds and large institutions have $6.84M invested in Immuneering in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.2M | |
| 2 | +$45.6K | |
| 3 | +$31.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.5K |
| 5 |
Morgan Stanley
New York
|
+$20K |
Top Sellers
| 1 | -$390K | |
| 2 | -$164K | |
| 3 | -$128K | |
| 4 |
Millennium Management
New York
|
-$121K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$121K |
